{"disease":{"id":"primary-myelofibrosis-prefibrotic-stage","name":"primary myelofibrosis prefibrotic stage"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04942080","title":"Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)","phase":"NA","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT03869476","title":"Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.","phase":"NA","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT04988815","title":"Ropeginterferon Alfa 2b for Early Myelofibrosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT03121599","title":"18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms","phase":"NA","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}